These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 10873752)
1. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Olszewska W; Obeid OE; Steward MW Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752 [TBL] [Abstract][Full Text] [Related]
2. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. Obeid OE; Partidos CD; Howard CR; Steward MW J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779 [TBL] [Abstract][Full Text] [Related]
3. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. Partidos C; Stanley C; Steward M Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995 [TBL] [Abstract][Full Text] [Related]
4. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response. Steward MW; Stanley CM; Obeid OE J Virol; 1995 Dec; 69(12):7668-73. PubMed ID: 7494275 [TBL] [Abstract][Full Text] [Related]
5. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431 [TBL] [Abstract][Full Text] [Related]
6. The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice. Obeid OE; Steward MW Immunology; 1994 May; 82(1):16-21. PubMed ID: 8045592 [TBL] [Abstract][Full Text] [Related]
7. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide. Partidos CD; Vohra P; Steward MW Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582 [TBL] [Abstract][Full Text] [Related]
8. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus. Steward MW Biologicals; 2001; 29(3-4):215-9. PubMed ID: 11851318 [TBL] [Abstract][Full Text] [Related]
9. Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy. Bouche FB; Steinmetz A; Yanagi Y; Muller CP Vaccine; 2005 Mar; 23(17-18):2074-7. PubMed ID: 15755573 [TBL] [Abstract][Full Text] [Related]
10. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus. Obeid OE; Stanley CM; Steward MW Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185 [TBL] [Abstract][Full Text] [Related]
11. Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen. Hathaway LJ; Obeid OE; Steward MW Vaccine; 1998; 16(2-3):135-41. PubMed ID: 9607021 [TBL] [Abstract][Full Text] [Related]
12. A Gag peptide encompassing B- and T-cell epitopes of the caprine arthritis encephalitis virus functions as modular carrier peptide. Niederhäuser S; Zahno ML; Nenci C; Vogt HR; Zanoni R; Peterhans E; Bertoni G J Immunol Methods; 2009 Mar; 342(1-2):82-90. PubMed ID: 19118559 [TBL] [Abstract][Full Text] [Related]
14. A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis. El Kasmi KC; Theisen D; Brons NH; Ammerlaan W; Klingele M; Truong AT; Muller CP Vaccine; 1999 May; 17(19):2436-45. PubMed ID: 10392626 [TBL] [Abstract][Full Text] [Related]
15. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides. Partidos CD; Obeid OE; Steward MW Immunology; 1992 Oct; 77(2):262-6. PubMed ID: 1385315 [TBL] [Abstract][Full Text] [Related]
16. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies. El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410 [TBL] [Abstract][Full Text] [Related]
17. The induction of respiratory syncytial virus-specific cytotoxic T-cell responses following immunization with a synthetic peptide containing a fusion peptide linked to a cytotoxic T lymphocyte epitope. Hsu SC; Shaw DM; Steward MW Immunology; 1995 Jul; 85(3):347-50. PubMed ID: 7558120 [TBL] [Abstract][Full Text] [Related]
18. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Khan AA; Babu JP; Gupta G; Rao DN Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277 [TBL] [Abstract][Full Text] [Related]
19. Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus. Wang YS; Fan HJ; Li Y; Shi ZL; Pan Y; Lu CP Vaccine; 2007 May; 25(22):4447-55. PubMed ID: 17445956 [TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine. Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]